Exacerbation of atrial fibrillation related to dulaglutide use

Abstract

Abstract Dulaglutide is associated with sinus tachycardia, increased PR interval, and 1st degree AV block. These conduction abnormalities can increase the risk of arrhythmia. Dulaglutide should be used with caution in patients with pre‐existing arrhythmia.

Keywords

• atrial fibrillation
• dulaglutide
• GLP‐1 receptor agonist